Amachiza abiza kakhulu e-2019
InkampaniAbantu baseMelika bachitha imali eninzi kumayeza amiselweyo kunaye nawuphi na umntu ehlabathini. Umyinge ophakathi wabemi baseMelika uchitha $ 1,025 ngonyaka kumachiza-oko kukunyuka kwamaxabiso okwenyuka oku-11 okonyukayo ukusukela nge1960, ngokwe idatha Ukusuka kwiZiko lasePeterson kwezempilo kunye neKaiser Family Foundation.
Kungenxa yokuba imimiselo iyabiza.
Amachiza ali-10 aqhelekileyo abhengeziweyo anoluhlu lwamaxabiso aqala kwi-488 yeedola ukuya kwi-16,938 yeedola ngenyanga okanye unyango, utshilo ISebe lezeMpilo kunye neNkonzo zoLuntu . Kwaye, uphando lwethu lubonisa ukuba uninzi lwamayeza amiselweyo rhoqo axabisa ngaphezulu kunoko.
Ngamanye amagama, zininzi kakhulu iziyobisi ezibizayo phaya. Ezi zezona ziyobisi zibiza kakhulu, ngokweedatha ye-SingleCare. Amaxabiso adweliswe apha ngezantsi abonisa ixabiso lemali ezinkozo-oko umthengi ekulindeleke ukuba ahlawule xa engenayo i-inshurensi okanye i-inshurensi yogqirha.
| Iziyobisi | I-avareji yexabiso lokubonelela ngeenyanga ezi-1 |
| Ummeli | Iidola ezingama-33,001.08 |
| Humira | $ 7,037.81 |
| Ungenelelo | $ 4,944.95 |
| Xeljanz | $ 4,694.13 |
| Forteo | $ 3,639.85 |
| Glatiramer acetate | $ 3,378.50 |
| I-Norditropin | $ 3,377.89 |
| Uluhlu | $ 3,356.06 |
| Atripla | $ 3,215.15 |
| Biktarvy | Iidola ezingama-3,214.05 |
1. Ummeli
Ixabiso leentsuku ezingama-28 zokubonelela: $ 33,001.08
I-Afinitor, iyeza le-chemotherapy elisetyenziselwa ukunyanga izintso, i-pancreatic, ibele, kunye nomhlaza wobuchopho, lelinye lawona mayeza abiza kakhulu phaya-kodwa abo banommiselo kufuneka babe nalo kwicebo labo lonyango. Rhoqo, ubude bonyango kunye ne-Afinitor buchazwa kukuchongwa kwezonyango. Izigulana ezifunyenwe zine-Subependymal Giant Cell Astrocytoma zifumene Ixesha lonyango iinyanga ezingama-24.4. Ixesha eliphakathi lonyango kwizigulana ezinesifo seRenal Cell Carcinoma ziintsuku ezili-141. Lixabiso elincinci le (gulp): $ 166, 184.01 kumjikelo wonyango ophakathi.
Okwangoku, ayikho enye into enokwenziwa xa kusenziwa amayeza ukunceda ukwehlisa iindleko. Umntu obeza kuba ngumenzi wejenerikhi uphulukene nelungelo lobunikazi ezinkundleni ngaphambili ngo-2019, eya kuthi ivumele ukwenziwa kwenguqulelo yohlobo oluqhelekileyo. Izigulana ezihlawula imali zibonwa kwi-tag yexabiso engama-33,000 kunye nexabiso. Kodwa kukho iindlela zokonga kwi-Afinitor 5 mg tablets. Ngoku ka Unyango ,Iipesenti ezili-100 ze-Medicare Icandelo D kunye nezicwangciso ze-Medicare Advantage zigubungela eli chiza.
2. Humira
Ixabiso leentsuku ezingama-28 zokubonelela: $ 7,037.81
I-Humira yi-immunosuppressant esetyenziselwa ukunyanga i-arthritis, i-psoriasis, isifo sika-Crohn, kunye ne-ulcerative colitis. Ibiyeyona nto ithengiswa kakhulu (aka yeyona inenzuzo) kweli lizwe ukusukela ngo-2012, kwaye ayibonisi zimpawu zokwehla. Kwi-2018, imimiselo kaHumira yenze ngaphezulu kwe- $ 14 yezigidigidi, eyayinyuke ngaphezulu kwe-60% kunonyaka ophelileyo- ngaphandle igama eliphikisayo amayeza e-biologic.
UKUYA Uphononongo luka-2016 epapashwe yi Ijenali yoMbutho Wezonyango waseMelika ongafumananga bungqina bokudibana phakathi kweendleko zophando kunye nophuhliso kunye namaxabiso; Endaweni yoko, amayeza amiselweyo axabisa ixabiso eUnited States ikakhulu kwisiseko sentengiso. Nangona kunjalo, iindleko zeHumira ziyaqhubeka nokunyuka.TIxabiso likaHumira liye lenyuka ukusuka kwi- $ 19,000 ngonyaka (ngo-2012) ukuya ngaphezulu kwe- $ 38,000 ngonyaka (ngo-2019), ngesigulana ngasinye, emva kwezaphulelo-ngokwedatha echazwe INew York Times , evela kwi-SSR Health, inkampani yophando. Olo kukunyuka kweepesenti ezili-100. Kodwa for Abo baxhomekeke kwiziyobisi, kukho iindaba ezimnandi ezizayo ngo-2023: ichiza le-biosimilar elibizwa ngokuba yiHyrimoz. Musa ukudideka ngamachiza enziwe afana nalawo aveliswe ngumenzi, ii-biosimilarsare ifana kakhulu amayeza asondele ngokwaneleyo ekuphindaphindweni ukufezekisa iziphumo ezifanayo zonyango kunye nezonyango (ngelixa i-genics ifana nemichiza efanayo kunyango lwantlandlolo). I-FDA ivume IHyrimoz kwaye iya kufumaneka e-United States nge-30 kaSeptemba 2023.
3. Unogogo
Ixabiso leentsuku ezingama-28 zokubonelela: $ 4,944.95
I-Enbrel yonyango ye-biopharmaceutical esetyenziselwa ukunyanga i-rheumatoid arthritis, i-psoriatic arthritis kunye nezinye iimeko ezizimele. NjengoHumira, u-Enbrel ubona ukunyuka kwentengiso kunye nemigqaliselo ezalisiweyo, ngaphandle kweendleko zokukhubaza isipaji.I-Enbrel-eyafika kwimarike yase-US kwi-1998-yabhala i-4.8 yezigidigidi zeedola kwintengiso yase-US e-2018, ngokutsho komvelisi Amgen , Inc.
Okwangoku, umenzi weziyobisi amaxabiso onikezelo ngonyaka we-Enbrel's 50-mg dose engaphezulu kwe- $ 67,000.Kwaye akukho generics kwihorizoni yokunceda ukunciphisa iindleko zezigulana.Ii-biosimilars ezimbini ze-Enbrel zamkelwe yi-FDA kwaye azikaziswa okwangoku-kubandakanya enye evela kumenzi weziyobisi waseSwitzerlandINovartis AGukuba i-arhente yezempilo ivume ngo-2016,ngoku ka Ijenali yeWall Street intatheli yezempilo UJared S. Hopkins . Ngaphezulu kwamalungelo awodwa omenzi wechiza akhusela i-Enbrel, kwaye umenzi wayo, u-Amgen Inc., uphumelele isigqibo senkundla ngo-Agasti esihambelana nelungelo lobunikazi le-Enbrel.
4. Xeljanz
Ixabiso leentsuku ezingama-30 zokubonelela: $ 4,694.13
I-Xeljanz yi-biopharmaceutical eyaziwayo emiselweyo ukunyanga i-rheumatoid arthritis, i-psoriatic arthritis, kunye ne-ulcerative colitis. Kodwa kutshanje, iyeza lenze iintloko ngenxa ye-FDA entsha isilumkiso esimnyama lontoi-JAK inhibitor ye-10-mg kabini idosi yemihla ngemihla, eyenzelwe ukunciphisa iintlungu kunye nokudumba,ukwandaumngcipheko wamahlwili egazi-kunye nokufa.
Timvume yeyeza ukunyanga i-ulcerative colitis iye yaxutywa-ngoku ivunyelwe kuphela kwizigulana ezingaphenduliyo okanye ezingalungelanga amanye amayeza.Kodwa ngaphandle kwazo zonke izilumkiso ezinzulu ezijikeleze idosi ye-10-mg, i-5-mg isathathwa njengekhuselekileyo, kwaye nayo ibonile ukwanda kwintengiso kunye nokusetyenziswa.
5. Forteo
Ixabiso leentsuku ezingama-28 zokubonelela: $ 3,639.85
I-Forteo lunyango olutofwayo olunceda ukomeleza amathambo kubantu abane-osteoporosis abasemngciphekweni omkhulu wokophuka-ngakumbi abo bane-osteoporosis ekuthatheni i-steroids njenge-prednisone. Yinto yokwenziwa kwehomoni ngokwendalo efumaneka emzimbeni ekhuthaza ukukhula kwethambo elitsha kunye nokwanda koxinano lwethambo. Inaliti zihlala zithathwa ethangeni okanye esiswini. Ivunyiwe ukuya kwiinyanga ezingama-24 zokusetyenziswa.
Okwangoku akukho generic ekhoyo. Kodwa, iPfenix iphumelele imvume yelungelo elilodwa lomenzi ngokufanayo imveliso , ezinokuqhuba ixabiso xa lihlasela imveliso. Sele zimbini iindlela zonyango eYurophu, kodwa ziye zavalwa eMelika. Ukuba ufuna iForteo, kukho ifayile ye- isaphulelo somenzi ziyafumaneka kwizigulana ezifanelekileyo.
6. Inaliti yeGlatiramer ye-Acetate
Ixabiso leentsuku ezingama-30 zokubonelela: $ 3,378.50
Inaliti yeglatiramer acetate yinguqulelo yohlobo oluqhelekileyo lwe ICopaxone , iyeza elitofwayo elisetyenziselwa ukunyanga i-multiple sclerosis kunye nokuthintela ukuphinda ubuye kwi-MS. Nokuba yinto eqhelekileyo, ixabiso liphezulu- hayi ngaphantsi kakhulu kunegama lomlingani.
Kule minyaka ingama-20 idlulileyo, bekukho inkqubela phambili enkulu kunyango lwe-MS, kodwa ukonyuka kweendlela ezikhoyo zokonyango azikhokelelanga ekuhleni ngokufanayo kumaxabiso. Baye benyuka. Ukusuka kwi-2013 ukuya kwi-2018, umndilili weendleko zesifo esiguqula iindlela zonyango ezinje nge-glatiramer acetate inyuke isuka kwi- $ 60,000 yaya kwi-80,000 yeedola ngokwe UMbutho weSizwe weMultiple Sclerosis . Ukuba unengxaki ekunikezeleni amayeza akho, UMylan unikezela ngokulondolozwa kwabantu abathile.
7. Inorditropin Inaliti
Ixabiso leentsuku ezingama-30 zokubonelela: $ 3,377.89
INorditropin yihomoni yokukhula eyenziwayo exelisa iihomoni kwincindi yebhinqa evuselela ukukhula emzimbeni: ukuphakama, amalungu, amathambo kunye nezihlunu. Xa isetyenziselwa abantwana abangenzi ngokwaneleyo ukukhula kwehomoni, inokubanceda babe bade. Kubantu abadala, inokukhuthaza ukukhula kwemisipha. Xa isetyenziselwa abaguli ngaphandle kokunqongophala, ayisebenzi.
Kucingwa njengonyango olukhethekileyo, njengalezo zisetyenziselwa ukunyanga iimeko ezinje ngomhlaza, i-HIV, okanye isifo samathambo. Ezi ndidi zamayeza zihlala zibiza kakhulu, kwaye i-norditropin ayikho ngaphandle. INovo Nordisk ine Inkqubo yokunceda isigulana endaweni yokunceda ukuhamba nge-inshurensi kunye nokufumana amayeza.
8. Stribild usetyenziso lweWindows kwi- Ivenkile yeWindows
Ixabiso leentsuku ezingama-30 zokubonelela: $ 3,356.06
I-Stribild yi-cocktail yeyeza ezine kwithebhulethi enye esetyenziselwa ukunyanga i-HIV kunye nokunciphisa umngcipheko wokuhambisa imeko kwabanye. Inamayeza amathathu ee-antiretroviral kunye neyeza elinceda abanye basebenze ngcono. Nangona ixabiso, kukho obunye ubungqina ukuba kanye ngemini unyango oludibeneyo lwe-HIV lixabisa ixesha elide kunezinye iindlela kuba ziphucula ukubambelela kunyango kwizigulana, ezinokuthi zinciphise umngcipheko weengxaki okanye ukulala esibhedlele. Umenzi weStrild, IGiliyadi , unikezela ngeenkqubo zoncedo lwesigulana ukuba unengxaki ekunikezeleni unyango.
9. I-Atripla
Ixabiso leentsuku ezingama-30 zokubonelela: $ 3,215.15
I-Atripla lelinye iyeza elidityanisiweyo elisetyenziselwa ukunyanga i-HIV, kunye nokwehlisa umngcipheko wokuhambisa le meko kwabanye. Iqulethe amayeza amathathu. Okwangoku akukho nguqulelo yamayeza enziwe afana nalawo aveliswe ngumenzi, egcina ixabiso liphezulu. Kodwa, ukuqala ukuphela kukaSeptemba 2020, Amayeza eTeva ivunyelwe ukwazisa iinguqulelo eziqhelekileyo, ezinokunceda ukuphucula iindleko. Umenzi weAtripla, IGiliyadi , unikezela ngeenkqubo zoncedo lwesigulana ukuba unengxaki ekunikezeleni unyango.
10. IBiktarvy
Ixabiso leentsuku ezingama-30 zokubonelela: $ 3,214.05
I-Biktarvy yipilisi yokudibanisa amayeza amathathu asetyenziselwa ukunyanga i-HIV. Akukho nguqulelo igeneric ifumanekayo. Entsha idatha ibonisa ukuba iyasebenza kakhulu kwizigulana ezitsha, kunye nezigulana ezitshintsha zivela kwamanye amayeza, ekhokelele phantse ukuphindaphindeka kabini ukuthengiswa kwala mayeza kunyaka omnye ngaphandle kwenkcitho. Njengamanye amayeza okudibanisa i-HIV, kukho ubungqina bokuba iyancipha iindleko zonyango lwexesha elide ngenxa yokubambelela kunyango. Umenzi weBiktarvy, IGiliyadi , unikezela ngeenkqubo zoncedo lwesigulana ukuba unengxaki ekunikezeleni unyango.
Ke yintoni ebangela amaxabiso aphezulu?
Njani (kwaye kutheni) indleko zamayeza amaninzi afunekayo aphezulu kangaka? Inzima-kwaye ichaphazeleka zizinto ezininzi.
Amayeza egama leBrand
Imakethi enegama lophawu kulapho aqala khona amayeza, kwaye ukuphuhlisa amayeza amatsha yinkqubo ebizayo netya ixesha. Amabhanti anelungelo elilodwa lomenzi kunye nokukhuselwa kwemithetho kwiminyaka yabo yokuqala yentengiso, evumela abavelisi ukuba basebenzise ngokupheleleyo imfuno yonyango lwabo lwenoveli, kwaye bavuze abatyali mali ngomonde wabo kunye neendleko eziphezulu zophando nophuhliso, ucacisa uDana Goldman, usihlalo womlawuli kwiziko le-USC Schaeffer Umgaqo-nkqubo wezeMpilo kunye noQoqosho kunye noNjingalwazi woMgaqo-nkqubo woLuntu, i-Pharmacy kunye ne-Economics. Ngamanye amagama, amaxabiso onyango amatsha aphezulu ngenxa yexabiso eliphezulu lokuwazisa.
Amayeza aqhelekileyo
Kwiimarike eziqhelekileyo, ibali elihlukile. Xa ipatent kwichiza elitsha liphela, abavelisi banokwenza uhlobo oluqhelekileyo kwaye balithengise ngexabiso eliphantsi kakhulu kuba umphuhlisi wokuqala uzibuyisile iindleko. Nangona kunjalo, ngamanye amaxesha, ii-generics ziyabiza kanye njengoogxa bazo abanophawu, njengexabiso elikhawulezileyo eliveliswa sisiyobisi IDaraprim , ezenza iindaba ngo-2015.
UMartin Shkreli kunye noTuring Pharmaceuticals bathathe i-13.50 yepilisi ngepilisi iDaraprim (esele ifumaneka ukusukela ngeminyaka yoo-1950) kwaye inyusa ixabiso laya kwi-750 yeedola ngepilisi. UShrkeli angakwenza oku kuba ixabiso leDaraprim lehle kakhulu kangangokuba bonke abathengisi babekhethe ukuphuma. Ukulingwa emva koko kwangena ngaphakathi kwaye kwaxhamla amandla ayo obukhosi phezu kwesiyobisi esasingenakho ukukhuselwa kwelungelo elilodwa lomenzi.
Oku kungqina indlela, ngokungaqhelekanga, amayeza aqhelekileyo Imarike ngamanye amaxesha inokusebenza kakuhle kakhulu: Iziyobisi zitshiphu kakhulu kwaye ukubonelelwa ngokwaneleyo kusemngciphekweni.
Inokunceda njani i-SingleCare
Ngenxa yeendleko eziphezulu zamayeza, abantu abaninzi ngakumbi baxhomekeke kwiinkampani zononophelo lwempilo ezifana Ukhathalelo ukubanceda ukugcina amakhulu (kunye namawaka) eedola kwimigqaliselo yabo. Kwi-SingleCare, sikholelwa ekubeni kubaluleke kakhulu ukubonelela ngezaphulelo kummiselo kuye wonke umntu waseMelika okhululekileyo ukufikelela, ngaphandle kwemeko yeinshurensi, utshilo uManav Malhotra, VP wedatha kwi-SingleCare. Kwaye njengoko sizama ukwenza ukuba amachiza afikeleleke ngakumbi kwaye afikeleleke, icandelo elikhulu lokuqinisekisa ukuba amaxabiso ayabonakala elubala kumthengi.
Kwaye ngelixa amaMelika esetyenziselwa ukuthenga ngeenxa zonke kumaxabiso, awenzi ngamayeza. Kunzima ukucinga ukuthenga nayiphi na imveliso ngaphandle koluvo lokuba iya kukubiza malini de ufike kwirejista, kodwa ke ngokwesiko ukuba ishishini lekhemisi lisebenza njani, utshilo uMalhotra. Sifuna abathengi bazi ngokuthe ngqo ukuba bazokuhlawula ntoni na kumaqabane ethu ekhemesti ngaphambi kokuba banyathele ngaphakathi. Abathengi abaninzi abazi nokuba amaxabiso ayahluka phakathi kweekhemesti ezingaphaya kwendlela. Intengiso eqhutywa ngumthengi onolwazi esenza izigqibo ezinolwazi linyathelo lokuqala lokunciphisa amaxabiso.
I-SingleCare inikezela ngeetshathi zokucaca kwexabiso ezikuvumela ukuba uthelekise ixabiso lemali kulondolozo lwe-SingleCare lweziyobisi kunyaka ophelileyo.Ukunikezela ngolondolozo olunokubakho kusentliziyweni yayo yonke into eyenziwa yi-SingleCare. Sijonge kwiziyobisi abathengi abazikhathaleleyo ngokwenene ukufumanisa ukuba zijolise phi iinzame zethu ekuqhubeni amaxabiso ezantsi, utshilo uMalhotra. Iqhuba indlela esenza ngayo izigqibo zethu zamaxabiso kunye neengxoxo zethu namaqabane ethu ekhemesti.
Qala ukukhangela amayeza akho Apha ukubona ukuba ungonga malini.
